Latest Period
Q2 2026
Security Snapshot
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) Institutional Ownership
CUSIP: 799566104
13F Institutional Holders and Ownership History from Q1 2021 to Q2 2026
Institutions Reporting
210
Shares (Excl. Options)
184,778,974
Price
$3.49
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- SANA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 184,778,974
- Total 13F value
- $644,751,358
- Portfolio coverage rank
- 0%
- Share change
- +20,507,104
- Value change
- +$76,862,799
- Number of holders
- 210
- Shares outstanding
- 299,825,487
- SEC-reported price per share
- $3.18
- Insider filing price
- $3.18
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 799566104.
- 210 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 202 to 210 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $473,080,134 to $644,751,358.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 210 institutions filings for Q2 2026.
Security key
799566104
Latest holder period
Q2 2026
13F holders
210
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
SANA full holder history
Sana Biotechnology, Inc. SEC filings
Sana Biotechnology, Inc. company facts
Sana Biotechnology, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 799566104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
SANA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P. | 15% | -11% | $181,460,381 | +$314,400 | 46,173,125 | +0.17% | Robert Nelsen | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 6.3% | $61,125,000 | 18,750,000 | RA Capital Management, L.P. | 14 May 2026 | |||
| BlackRock, Inc. | 5.1% | +4% | $55,528,247 | +$10,647,588 | 13,643,304 | +24% | BlackRock, Inc. | 31 Dec 2025 |
| VANGUARD GROUP INC | 4.8% | $19,023,535 | 10,747,760 | The Vanguard Group | 31 Dec 2024 |
As of 30 Jun 2026, 210 institutional investors reported holding 184,778,974 shares of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA). This represents 62% of the company’s total 299,825,487 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
56%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 12% | 37,429,515 | -0% | 0.01% | $130,629,007 |
| Flagship Pioneering, LLC | 8.3% | 25,001,856 | 0% | 5.7% | $87,256,477 |
| RA CAPITAL MANAGEMENT, L.P. | 6.3% | 18,750,000 | 0.57% | $65,437,500 | |
| BlackRock, Inc. | 5.6% | 16,675,173 | +17% | 0% | $58,196,354 |
| STATE STREET CORP | 3.7% | 11,203,134 | +6.3% | 0% | $39,098,938 |
| CANADA PENSION PLAN INVESTMENT BOARD | 3.4% | 10,218,400 | -0.03% | 0.02% | $35,662,216 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8% | 8,375,421 | +13% | 0% | $29,230,219 |
| BANK OF AMERICA CORP /DE/ | 1.9% | 5,748,454 | +95% | 0% | $20,062,105 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 4,677,959 | +12% | 0% | $16,329,082 |
| Marex Group Ltd | 1.3% | 3,989,100 | -0.25% | 0.1% | $13,921,959 |
| MARSHALL WACE, LLP | 0.98% | 2,931,436 | +341% | 0.01% | $10,230,711 |
| Alphabet Inc. | 0.94% | 2,812,500 | 0% | 0.01% | $9,815,625 |
| GOLDMAN SACHS GROUP INC | 0.79% | 2,367,935 | -26% | 0% | $8,264,094 |
| Integral Health Asset Management, LLC | 0.67% | 2,000,000 | -38% | 0.29% | $6,980,000 |
| TORONTO DOMINION BANK | 0.66% | 1,972,381 | 0.01% | $6,883,610 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.63% | 1,881,689 | +10% | 0% | $6,567,095 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.62% | 1,868,718 | 0.02% | $6,521,826 | |
| NORTHERN TRUST CORP | 0.54% | 1,604,084 | +8.5% | 0% | $5,598,252 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.46% | 1,379,181 | +0.95% | 0% | $4,813,342 |
| Woodline Partners LP | 0.44% | 1,317,932 | 0% | 0.01% | $4,599,583 |
| VANGUARD FIDUCIARY TRUST CO | 0.41% | 1,237,437 | +16% | 0% | $4,318,655 |
| RENAISSANCE TECHNOLOGIES LLC | 0.41% | 1,231,100 | -15% | 0.01% | $4,296,539 |
| MORGAN STANLEY | 0.38% | 1,139,782 | -22% | 0% | $3,977,839 |
| UBS Group AG | 0.35% | 1,061,441 | -22% | 0% | $3,704,429 |
| AQR CAPITAL MANAGEMENT LLC | 0.32% | 963,147 | -14% | 0% | $3,361,383 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
22
Latest
Q2 2026
Rows shown
1-22 of 22
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 184,778,974 | $644,751,358 | +$76,862,799 | $3.49 | 210 |
| 2026 Q1 | 164,234,379 | $473,080,134 | +$13,118,650 | $2.88 | 202 |
| 2025 Q4 | 159,112,907 | $647,601,557 | -$17,518,558 | $4.07 | 201 |
| 2025 Q3 | 163,544,919 | $580,597,886 | +$66,158,610 | $3.55 | 175 |
| 2025 Q2 | 145,417,350 | $397,022,759 | -$12,602,331 | $2.73 | 152 |
| 2025 Q1 | 149,116,670 | $250,510,959 | -$14,520,086 | $1.68 | 156 |
| 2024 Q4 | 157,928,176 | $257,417,788 | -$2,121,232 | $1.63 | 159 |
| 2024 Q3 | 153,260,123 | $637,634,346 | +$16,640,858 | $4.16 | 150 |
| 2024 Q2 | 148,167,660 | $809,021,070 | +$44,986 | $5.46 | 144 |
| 2024 Q1 | 146,274,865 | $1,462,752,586 | +$233,741,262 | $10.00 | 151 |
| 2023 Q4 | 124,526,898 | $508,113,977 | -$12,215,240 | $4.08 | 128 |
| 2023 Q3 | 127,513,989 | $493,495,510 | -$30,211,194 | $3.87 | 132 |
| 2023 Q2 | 134,904,538 | $804,023,148 | +$26,527,612 | $5.96 | 121 |
| 2023 Q1 | 130,716,654 | $427,414,965 | +$6,519,444 | $3.27 | 118 |
| 2022 Q4 | 128,403,041 | $507,152,945 | -$769,516 | $3.95 | 119 |
| 2022 Q3 | 128,339,963 | $769,886,255 | +$13,983,486 | $6.00 | 122 |
| 2022 Q2 | 125,590,881 | $807,500,039 | +$40,235,857 | $6.43 | 111 |
| 2022 Q1 | 119,405,403 | $985,831,531 | +$36,653,787 | $8.26 | 109 |
| 2021 Q4 | 111,562,858 | $1,727,117,718 | +$20,231,159 | $15.48 | 101 |
| 2021 Q3 | 75,725,736 | $1,706,389,522 | +$266,392,448 | $22.52 | 85 |
| 2021 Q2 | 64,059,346 | $1,259,281,145 | +$104,914,051 | $19.66 | 78 |
| 2021 Q1 | 58,277,829 | $1,950,553,711 | +$1,950,553,686 | $33.47 | 74 |